SCHEMBL25822069

SCHEMBL25822069

C=C(C)C1(c2ccc3c(N)ncnn23)O[C@H](COCCCC)[C@@H](OCCCC)[C@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25822075 0.92 RIPK1 (0.30) —
SCHEMBL10143786 0.87 — —
SCHEMBL10142421 0.87 — —
SCHEMBL10142123 0.85 — —
SCHEMBL12454580 0.84 — —
SCHEMBL12454579 0.84 — —
SCHEMBL17215194 0.84 — —
SCHEMBL25822058 0.83 — —
SCHEMBL23960116 0.82 HSPA5 (0.35) —
SCHEMBL17722654 0.82 TMPRSS2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219993-A1 ANTIVIRAL APPLICATION OF NUCLEOSIDE ANALOG OR COMBINATION FORMULATION CONTAINING NUCLEOSIDE ANALOG VIGONVITA LIFE SCIENCES CO., LTD. (CN) 2023-07-13 — — US disclosed
Send feedback